Axcella Therapeutics is a startup based in the United States, 1 tracked investor.
Based in the United States, Axcella Therapeutics is a startup founded in 2012. Brouky records 1 investor associated with the company.
Axcella Therapeutics develops novel orally delivered therapeutics based on endogenous metabolic modulators to treat complex diseases by restoring metabolic function.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.